APH 0.00% 17.0¢ australian primary hemp limited

no idea

  1. 156 Posts.
    The people who comment here seems to have no idea at all about Biotechs.
    Remember a biotech called Gropep, well they had 80mil shares and went from 0.40 to $1.60 on a profit of $4mil per annum until they were bought out for $2.05.
    ACL gets 50% of lets say conservatively $200mil = $100mil - costs 50% = $50mil profit.
    Now when the sales go into the billions then this could become another ACL but I suspect they will be taken out by a major pharma long before then.
    My broker my broker sell your shares now. if you dont understand phase1, phase2, phase3 trials and ANDA.
    Once you get to ANDA it is a 98% certainty to get approval especially as itm is a generic and better that the original.
    At preclinical 98% of drugs fail, at Phase1 80% of drugs fails, get the picture, tell that to your broker broker.
watchlist Created with Sketch. Add APH (ASX) to my watchlist
(20min delay)
Mkt cap ! $11.85M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 104988 17.0¢

Sellers (Offers)

Price($) Vol. No.
17.5¢ 9090 1
View Market Depth
Last trade - 07.00am 30/09/2020 (20 minute delay) ?
APH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.